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Fungal Speciation Using Quantitative
Polymerase Chain Reaction (QPCR)
in Patients With and Without
Chronic Rhinosinusitis
Andrew H. Murr, MD; Andrew N. Goldberg, MD, MSCE; Stephen Vesper, PhD
Objectives/Hypothesis: The objectives of this
study were to determine the mycology of the middle
meatus using an endoscopically guided brush sam-
pling technique and polymerase chain reaction labo-
ratory processing of nasal mucous; to compare the
mycology of the middle meatus in patients with sinus
disease with subjects without sinus disease; to com-
pare the responses on two standardized quality-of-life
survey forms between patients with and without si-
nusitis; and to determine whether the presence of
fungi in the middle meatus correlates with responses
on these data sets. Study Design: The authors con-
ducted a single-blind, prospective, cross-sectional
study.Methods:Patientswith sinus disease and a con-
trol group without sinus disease were enrolled in the
study. A disease-specific, validated Sinonasal Out-
comes Test survey (SNOT-20) was completed by the
subjects and a generalized validated Medical Out-
comes Short Form 36 Survey (SF-36) was also com-
pleted. An endoscopically guided brush sampling of
nasal mucous was obtained from the middle meatus.
Fungal specific quantitative polymerase chain reac-
tion (QPCR)was performedon the obtained sample to
identify one of 82 different species of fungus in the
laboratory. Statistical analysis was used to categorize
the recovered fungal DNA and to crossreference this
information with the outcomes surveys. Results: The
fungal recovery rate in the study was 45.9% in pa-
tients with sinus disease and 45.9% in control sub-
jects. Patientswith chronic rhinosinusitis had amean
SNOT-20 score of 1.80 versus the control group mean
score of 0.77 (P < .0001). SF-36 data similarly showed
a statistically significant difference between diseased
and control populations with controls scoring amean
of 80.37 and patients with chronic rhinosinusitis scor-
ing a mean of 69.35 for a P value of .02. However, no
statistical significance could be ascribed to the pres-
ence or absence of fungi recovered, the type of fungi
recovered, or the possible impact of fungi on the
quality-of-life survey results. Conclusion: The recov-
ery rate of fungi from the middle meatus of patients
with chronic rhinosinusitis and a control population
without chronic rhinosinusitis is 45.9% using QPCR
techniques. No direct causation with regard to fungal
species or presence was proven; however, a species
grouping for future studies is proposed based on
trends in this data and other reports. Disease-specific
outcomes surveys revealed a statistically significant
difference between the two groups. Key Words: Fun-
gus, sinusitis, polymerase chain reaction, middle me-
atus, group I and group II fungi.
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INTRODUCTION
Despite many years of investigatory effort, the patho-
physiology of chronic rhinosinusitis (CRS) remains elu-
sive. The purpose of this study is to define the speciation
of fungal elements found in patients with accurately diag-
nosed CRS and to compare the flora distribution with pa-
tients with no sinus disease or complaints. Previous testing
techniques using fungal cultures sample nonspecific areas in
the nose from the nasal vestibule to the nasopharynx. To
alleviate this source of uncertainty concerning quantity and
location of sampling, a quantitative polymerase chain reac-
tion (QPCR) method was used to process the specimens
obtained from themiddle meatus under endoscopic guidance
for speciation. Our results are presented with analysis and
statistical review.
Sinusitis is the most common chronic condition for
which a patient seeks the input of a physician. It is com-
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monly quoted that sinusitis accounts for between 22 and
30 million patient visits per year.1 A huge pharmaceutical
industry exists to produce drugs that have an effect on
sinus conditions with sales figures in the billions of dol-
lars. Panels and cooperative groups have met to try to
create a standardized terminology to define sinusitis. The
disease is often conveniently broken down into “acute
sinusitis” and “chronic sinusitis” based on the time course
of existing symptoms despite treatment. Chronic rhinosi-
nusitis is often defined as a disorder of the sinuses that
has been present for 12 weeks and persists despite treat-
ment. It is presumptive that acute or subacute rhinosinus-
itis clears within 3 months.2
Radiologic studies have been used to help define and
diagnose sinus disease and computed tomography (CT) scan
findings often play into the definition of whether rhinosinus-
itis is present or has cleared. Yet, findings on radiologic
studies are not specific as to the causation of disease.3 In
fact, a simple upper respiratory infection can produce CT
findings indistinguishable from CRS on film review and yet
be entirely reversible with either little or no directed treat-
ment.4 Perhaps the reason for this confusion is that the
causation of rhinosinusitis itself is currently not properly
defined. Although the model of a simple bacterial or viral
infection is suitable for understanding acute rhinosinusitis,
an all-encompassing model of CRS clearly does not exist
because this form of the disease presents with much greater
variability. Chronic rhinosinusitis may or may not be accom-
panied by nasal polyposis, atopic allergy, fungal infection,
chromosomal abnormality, immune dysfunction, or other
metabolic dysfunction.
Much recent work has been done to help define the
role of antifungal treatment in CRS.5 Fungi may partici-
pate in the pathophysiology of CRS in a variety of ways
either as a direct invasive infection as is seen in mucor-
mycosis or as an IGE-mediated inflammatory agent as
seen in allergic fungal sinusitis (AFS).6–8 Other mecha-
nisms of fungal participation in sinus inflammation have
been proposed, including the concept of allergic mucin
fungal sinusitis and the concept described in culture-
based studies, which implicates a causative mechanism
based on eosinophil-mediated chronic inflammation.9,10
This latter concept was unique enough to warrant issu-
ance of a U.S. patent for the application of antifungal
medication “for treating and preventing inflammation of
mucosal tissue”.11
Although the presence of fungus itself in the nasal
cavity of a patient would have at one time been thought to
be unusual or even alarming, it has now been shown that
the presence of fungal elements in the nasal respiratory
tract is in fact common.10,12,13 A culture-based study has
implied that all humans with or without sinus infection
retain fungus in the nasal cavity as part of the background
flora.10,12 A QPCR study has shown that a large percent-
age of patients with or without sinusitis have fungal ele-
ments present in the nasal cavity.13 Furthermore, a sec-
ond QPCR-based study has shown that the quantity of
fungus in the nasal cavity is the same in patients with or
without sinus disease.14 A culture-based study has shown
that newborn infants do not have fungus in their nasal
cavity when born; however, by the age of 6 weeks, infants
universally have nasal fungus that can be cultured using
special techniques.12
Some previously idiopathic diseases have been associ-
ated through QPCR identification techniques with group-
ings of fungal species. Vesper et al. in a study of water-
damaged, moldy homes found that there are 26 molds
associated with water-damaged environments and that 10
fungal species are present in essentially all homes.15 They
were able to link the species recovered in water-damaged
environments with idiopathic pulmonary hemorrhage.15
This study categorized the fungi found in a water-damaged
environment as group Imolds and refers to other fungi found
commonly in a household environment as group II molds15,16
(Table I). We have used this same grouping to look at the
occurrence of molds in this study of patients with CRS and
compared the results with findings in a group of control
patients.
MATERIALS AND METHODS
Patients were recruited for the study during routine care
appointments in an outpatient clinical practice centering on rhi-
nology and general otolaryngology/head and neck surgery. In-
formed consent was obtained from all patients for obtaining nasal
samples as part of clinical care and the study was approved by the
Institutional Committee on Human Research. Individuals were
recruited for the study in two broad groups: patients with CRS
and patients and other participants without CRS. Patients with
CRS had a history of chronic sinusitis for greater than 3 months
despite medical management. All patients had nasal endoscopic
signs of CRS such as visible mucopurulent drainage or nasal
polyposis on physical examination. All patients with rhinosinus-
itis had evidence of CRS on CT examination. Patients with im-
mune compromise, minors, and pregnant patients were excluded
from the study. Individuals without rhinosinusitis were undergo-
ing nasal endoscopy as part of a general otolaryngology/head and
neck surgery office examination for reasons unrelated to rhinosi-
nusitis or allergy, had no complaints or history pertaining to CRS,
and had no history of a recent upper respiratory infection. All
patients in the control population had a negative nasal endoscopy
examination for signs of sinus disease.
Subjects filled out two validated quality-of-life questionnaires:
a Standard Form-36 Heath Survey (SF-36) general quality-of-life
outcomes measure and a Sino-Nasal Outcomes Test (SNOT-20)
rhinosinusitis-specific quality-of-life instrument.17,18 Subjects were
given 0.5% Neo-Synephrine aerosolized spray and 1% tetracaine
aerosolized spray to allow comfort during the initial endoscopic
examination. A 30° Hopkins rod attached to a camera and light
source were used to guide an Interdental Brush (Acclean; Henry
Schein Inc., Melville, NY) into the middle meatus under direct
visualization. The brush had been steam-sterilized and packaged in
a peel pack in keeping with standard office instrument processing.
After swabbing the middle meatus and removing mucous from this
area, the brush was placed in a 2-mL conical bottom, screw-cap tube
(506–636; PGC Scientifics, Gaithersburg, MD). The specimen was
then refrigerated and transported to the laboratory on ice packs.
Quantitative Polymerase Chain Reaction Assays
and Standard Curves
Methods used in this study have been reported for preparing
conidia or spore suspensions from fungal cultures, extracting DNA,
performing QPCR analyses, and preparing standard calibration
curves for target conidia or spore equivalents versus delta cycle
threshold values (CT  CT,target  CT,reference) using coextracted
DNA from Geotrichum candidum as an exogenous reference.19,20
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Methods for estimating the amplification factors and extrapolating
spore or conidia sensitivities of the assays from the standard curves
have also been described.21 All primer and probe sequences used in
the assays as well as known species comprising the assay groups are
at the web site: http://www.epa.gov/nerlcwww/moldtech.htm. Prim-
ers and probes were synthesized commercially (Applied Biosystems,
Foster City, CA; Integrated DNA Technologies, Coralville, IA;
Sigma Genosys, Woodlands, TX).
DNA Extractions and Quantitative Polymerase
Chain Reaction Enumeration of Molds
Eighty-two molds selected because of their common environ-
mental presence were assayed in each of the samples.15 Positive
control suspensions, containing approximately 104 or 105 spores or
conidia/mL of each of the standard cultures, were prepared.21 Sam-
ples and positive control suspensions were extracted by a rapid
bead-milling method.19 Briefly, 0.3 g of glass beads (G-1277; Sigma,
St. Louis, MO) and 100 and 300 L of lysis and binding buffer,
respectively, from an Elu-Quik DNA Purification Kit (Schleicher
and Schuell, Keene, NH) with 10 L of a 2  108 conidia/mL
reference suspension of G. candidum were added to the 2-mL tube
containing the sampling brush. The tubes were shaken in a Mini
Bead-Beater (Biospec Products, Bartlesville, OH) for 1 minute at a
maximum speed and then centrifuged for 1 minute at 8,000  g to
pellet the glass beads and debris. The supernatants were further
purified using a DNeasy kit (Qiagen, Valencia, CA).
TABLE I.
Group I and Group II Molds as Classified by Vesper et al.15
Group I Fungi (26 species) Group II Fungi (10 species)
Predominate in water-damaged environments Ubiquitous in homes
Aspergillus flavus group Aspergillus ustus
A. flavus and A. oryzae Penicillium chrysogenum savar.2
Aspergillus fumigatus group Acremonium strictum
A. fumigatus and Neosartorya fischeri Alternaria alternata
Aspergillus niger group Cladosporium cladosporioides–svar.1
A. niger, A. foetidus, A. pheonicis Cladosporium cladosporioides–svar.2
Aspergillus ochraceus group Cladosporium herbarum
A. ochraceus and A. ostianus Epicoccium nigrum
Aspergillus penicillioides Mucor and Rhizopus group
Aspergillus restrictus group M. amphibiorum, M. circinelloides, M. hiemalis,
M. indicus, M. mucedo, M. racemosuus,
M. ramosissimus, R. azygosporus,
R. homothalicus, R. microsporus,
R. oligosporus, R. oryzae Rizopus stolonifer
A. restrictus, A. caesillus, A. conicus
Aspergillus sclerotiorum
Aspergillus sydowii
Aspergillus unguis
Aspergillus versicolo
R Eurotium group
E. amstelodami, E. chevalieri, E. herbariorum,
E. rubrum, E. repens.
Penicillium brevicompactum
Penicillium group 2
P. crustosum, P. camembertii, P. commune,
P. echinulatum, P. solitum
Penicillium corylophilum
Penicillium purpurogenum
Penicillium spinulosum group
P. spinulosum, P. glabrum, P. lividum,
P. pupurescens, P. thomii
Penicillium variablile
Paecilomyces variotii
Aureobasicium pullulans
Chaetomium globosum
Cladosporium sphaerospermum
Scopulariopsis brevicaulis
Scopulariopsis chartarum
Stachybotrys chartarum
Trichoderma viride group
T. viride, T. atroviride, T. koningii
Wallemia sebi
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QPCR assays for target organism and G. candidum refer-
ence DNA in the extracts were prepared using a “Universal
Master Mix” of PCR reagents (Applied Biosystems, Foster City,
CA) and performed in an Applied Biosystems Prism model 7700
sequence detection instrument. Numbers of spores or conidia
detected in mucous brush samples (N) were calculated using the
equation: log10 (N)  (CT  a)/b, where CT was the difference
in observed CT values between the target and reference organ-
isms (CT,target  CT,reference) for the respective mucous brush sam-
ple and “a” and “b” were the mean y-intercept and slope param-
eter values from the standard calibration curves for each target
assay group. Parallel analyses of method negative control sam-
ples, containing AE buffer only, were performed at a frequency of
approximately one per each six test samples analyzed. All posi-
tive results were confirmed by two additional replications.
RESULTS
Seventy-four subjects were enrolled in the study and
had laboratory specimens processed for fungi detection.
Sixty-five subjects filled out the SF-36 completely and 71
subjects filled out the SNOT-20 survey completely. Thirty-
seven subjects were in the control group and 37 patients
had CRS.
The laboratory tested for 36 fungal species initially
and then expanded the range to investigate for 82 fungi.
Of the initial 36 species, positive identification was
achieved for 13 of the species sought. When the investiga-
tion was broadened to search for an additional 46 fungal
species, only two new organisms were identified: Aspergil-
TABLE II.
Number of Cell Equivalents Detected in Control Subjects by Patient Identification Code for Each Detected Mold Species But Only for
Samples in Which at Least One Mold Was Detected.
Fungal ID 81 82 85 86 87 29 43 44 49 50 51 52 53 55 56 60 65
Aspergillus niger
Aspergillus penicillioides 6 7 4
Eurotium (Asp.) amstelodami 2
Aureobasidium pullulans 10 3 10
Penicillium crustosum (group II)
Stachybotrys chartarum 1 1 1
Trichoderma viride/koningii 15 2
Aspergillus ustus
Cladosporium cladosporioides-1 1 1 1 1 1 1 1
Cladosporium cladosporioides-2
Cladosporium herbarum 1
Epicoccum nigrum 3 1
Mucor group
Aspergillus terreus
Penicillium expansum
TABLE III.
Number of Cell Equivalents Detected in Patients With Chronic Rhinosinusitis by Patient Identification Code for Each Detected Mold
Species But Only for Samples in Which at Least One Mold Was Detected.
Fungal ID 1 3 7 8 9 14 16 19 22 27 34 36 42 45 48 67 68
Aspergillus niger 1
Aspergillus penicillioides 7
Eurotium (Asp.) amstelodami 2 2
Aureobasidium pullulans 4 2 43
Penicillium crustosum (group II) 1538
Stachybotrys chartarum 1 1
Trichoderma viride/koningii 8 4
Aspergillus ustus 2 1
Cladosporium cladosporioides-1 9 1 2 1 1 2 1
Cladosporium cladosporioides-2 1
Cladosporium herbarum 254 1
Epicoccum nigrum 3 6 1
Mucor group 1
Aspergillus terreus 3
Penicillium expansum 286
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lus terreus and Penicillium expansum. The most common
organism identified was Cladosporium cladosporioides-1
with 14 individuals having evidence of this organism in
their samples. There was no statistical difference between
the presence of Cladosporium cladosporiodes-1 in the dis-
eased and control groups with a Fisher’s exact ratio of
1.000. The second most common organisms isolated were
Aureobasidium pullulans, which was identified in six in-
dividuals, and Epicoccum nigrum and Stachybotrys char-
tarum, which were identified in five individuals each.
Statistical significance was not achieved between diseased
and control populations in this small group using Fisher’s
exact method to examine the distribution of these organ-
isms. Tables II and III summarize the identified organ-
isms found in this study in the control and CRS groups,
respectively.
Fisher’s exact method was used to crossreference the
species of fungus isolated and determine whether the pres-
ence of any particular fungus could predict whether a subject
was in the CRS or control group. This did not reveal statis-
tical significance. Crossreferencing SNOT-20 and SF-36
scores with the presence or absence of fungal identification
did not show a statistical trend between diseased and control
populations using the Mann-Whitney method.
The yield of the QPCR method for detecting fungi in
this population was 45.9% in both the CRS and the control
groups. Seventeen of 37 patients in the diseased group
had fungus identified in the laboratory for a recovery rate
of 45.9% and 17 of the 37 subjects in the control group had
fungi recovered for a yield of 45.9%.
There were 15 mold species found in these samples.
Half of the control and half of the CRS patient samples
had no detectable molds. Most species occurred at less
than 10 cells per sample in control subjects (Table II). In
a few CRS cases, however, relatively large numbers of
cells were detected (Table III). No individual species was
significantly correlated with CRS. Therefore, molds were
grouped as previously described (Table I).15,16
Mold was detected 30 times in patients with CRS and
22 times in control subjects (Table IV). Seven were members
of the group I molds associated with water damage and
were found in both the patients with CRS and the control
subjects. There were two species, Aspergillus terreus and
Penicillium expansum, detected but these were not part of
the group classification system. Positive results for any
group I mold were seen in 12 of 37 samples from patients
with CRS and 12 of 37 for controls. For group II species,
the incidence was 16 of 37 in patients with CRS versus 10
of 37 for the control individuals. This gives a Fisher’s exact
test (one-tailed) P value of .24 when comparing group II
molds in the patients with CRS with control subjects. No
individual mold assay was able to discriminate between
CRS and control patients any better than the presence/
absence of any group 2 species. This was not statistically
significant.
Statistically significant responses were found on the
SNOT-20 survey when comparing the sinusitis and control
groups using the Mann-Whitney calculation. Diseased pa-
tients reported worse symptoms with a mean score of 1.807
compared with controls responding with a mean score of
0.768 (P value of .0001). The SF-36 results also showed
statistically significant differences in responses with the
overall score of the patients with CRS at a mean of 69.350
and the control group reporting a mean score of 80.373 (P 
.0201). Certain dimensions of the SF-36 revealed a difference
in scoring between the two groups with the sinusitis group
reporting statistically significant impaired function in the
categories of role limitation resulting from physical health or
PH (P  .0236), social functioning or SF (P  .0360), and
general health or GH (P  .0005).
DISCUSSION
This study was designed to test the yield of an endo-
scopically directed brush sampling technique of the mid-
dle meatus for the presence of fungus as identified with a
highly accurate QPCR laboratory protocol. In addition, the
study was designed to compare populations of patients
with sinus disease with a cohort of subjects without
sinusitis-related symptoms or signs of sinus disease. Com-
parison between these groups was accomplished using
standardized outcomes surveys (SNOT-20 and SF-36) and
also laboratory analysis for fungal DNA of the obtained
mucous specimens.
Numerous studies now have been accomplished to de-
scribe the mycology of the human nose.10,12–14 The investi-
gations can essentially be broken down into two types: those
that use culture identification methods and those that use
QPCR identificationmethods.10,12–14,22–35 Although the tech-
niques used by two investigators processing specimens by a
culture method reveal a yield of close to 100% in either
diseased or control populations, others that have attempted to
duplicate this yield have not been as successful.12,13,22,25–31,33,35
Perhaps the most interesting comparison of patients
using the culturemethod studied a cohort of newborn infants
TABLE IV.
Occurrence of Group I and II Molds in Patients With Chronic
Rhinosinusitis (CRS) and Control Subjects.
Fungal ID
CRS Patients Control Subjects
Occurrence Occurrence
Group I
Aspergillus niger 1 0
Aspergillus penicillioides 1 3
Eurotium (Asp.) amstelodami 2 1
Aureobasidium pullulans 3 3
Penicillium crustosum (group II) 1 0
Stachybotrys chartarum 2 3
Trichoderma viride/koningii 2 2
Group II
Aspergillus ustus 2 0
Cladosporium cladosporioides-1 7 7
Cladosporium cladosporioides-2 1 0
Cladosporium herbarum 2 1
Epicoccum nigrum 3 2
Mucor amphibiorum/. . group 1 0
Unclassified
Penicillium expansum 1 0
Aspergillus terreus 1 0
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and followed them over time to see if they would develop
laboratory evidence of nasal fungal colonization.12 In this
study, most newborns did not have fungus in their nose on
birth but developed fungal colonization over time without
showing signs of clinical disease. It could be argued that the
fungal laboratory culture technique leads to contamination
and that this is why the yields approach 100% in some
studies. Yet, the fact that the early newborn cultures did not
become positive over time argues strongly against laboratory
contamination as an explanation for near 100% yields.
Rather, it may be the collection technique itself that leads to
specimens being contaminated at the outset. The high-yield
culture studies use a nasal irrigation technique to collect
mucous.10,12 A small amount of saline is irrigated into the
nose for several seconds and then collected for laboratory
processing. This irrigation technique likely samples the na-
sal vestibule, lower nasal mucosal surfaces of the inferior
turbinate, and perhaps the nasopharynx and olfactory cleft.
It is rather indiscriminate as to the specific origin of the
washing irrigant. This present study reveals a fungal yield of
approximately 45%. Our yield is similar to other QPCR
techniques reported in the past.13,14,26,32,33 However, the
present study was specific to the mycology of the middle
meatus because the samplings were obtained under direct
endoscopic guidance. Two QPCR-based studies have shown
higher fungal yields than revealed in this report, but onewas
obtained from surgical material and the other used an irri-
gation technique that was not specific to the middle me-
atus.31,35 Yet, when diseased and nondiseased patients are
compared, no statistical difference is revealed between the
presence or absence of fungus, the species of fungus, or the
number of different fungi present.
Other studies have sought to reveal the mycology of
the nose and have shown a similarly variable distribution
of fungi as revealed in this report.12,28 The investigation
by Lackner et al. revealed that approximately 20% of
specimens taken from newborn infants grew fungi when
sampled immediately after birth, but this rate dropped to
approximately 15% on the next several days of life only to
rise to the 90% range for a myriad of fungi at 2 to 5 months
of life.12 Jiang et al. noted a higher yield on lavage speci-
mens when compared with a swab-sampling method using
a culture technique, but was still only able to approach a
50% yield when using “Ponikau’s method” compared with
an 11.8% method using the swab.28 A directed swab sam-
pling method of infants reported by Hannula et al. found
a 43% positive yield for fungi in the nasopharynx and
oropharynx of 2- to 4-month-old infants.36
Obviously, the technique chosen as a method to sam-
ple the nose is important with respect to the expected
yield. There are, however, certain disadvantages to the
culture method. The culture method requires a week’s
worth of specialized laboratory processing and therefore
results are not immediately available. In addition, to re-
veal the specific identification of the fungi found, QPCR
methods may be necessary to finalize the specific genus
and species of the growing fungal colonies. QPCR tech-
niques are extraordinarily accurate because the identifi-
cation is based on specific DNA coding. Therefore, accu-
rate identification is essentially instantaneous. QPCR
also avoids prolonged laboratory culturing and has the
potential to reveal a quick result. Also, it does not appear
that directed culture techniques can duplicate the yields
found in irrigation methods of sampling as evidenced by
our results. In fact, the directed culture techniques seem
to have a yield lower than the QPCR-based methods that
show a yield of approximately 40% to 60%.13,14,22,28 It is
possible that the irrigation techniques are too indiscrimi-
nate to provide accurate information on the mycology of
the middle meatus or of a specific nasal region.
This study was successful in revealing the mycology
of a specific region of the nose in patients afflicted with
sinusitis and in subjects without sinus complaints or evi-
dence of sinus disease. The results are generally similar to
other investigations in that a vast variety of organisms
was identified. This vast and variable flora precluded
identifying a statistically significant culprit or group of
culprits underlying rhinosinusitis in the diseased popula-
tion. Other studies have revealed a predominance of As-
pergillus species25,30 or a general trend toward identifying
Penicillium species.12 Others have found Alternaria, Pen-
icillium, Aspergillus, and Cladosporium species that seem
to predominate.10 This study showed a predominance of
Cladosporium species from specific middle meatus sam-
pling. Other fungi, including Aspergillus, Aureobasidium,
Epicoccum, and Stachybotrys, were also identified fre-
quently. It is interesting that Alternaria species were not
identified in this study because it is a prominent finding in
other studies.10,30 No conclusions can be drawn from this
flora distribution, but this study does reveal the mycology
of a specific region of the nose in that the specimens were
directly sampled from the middle meatus.
From a statistical perspective, it is a daunting task to
attempt a study that will have the statistical power to
definitively prove a relationship between a specific fungus
and sinus disease, especially given the multifactorial cau-
sation of sinusitis and the ubiquitous nature of molds in
the environment. On the other hand, neither has the con-
verse been proven: neither is it certain that a single
fungus or group of fungi is not particularly related to the
presence of CRS.
Some investigators have attempted to narrow the
statistical beta error by grouping fungi together when
looking at causation. Vesper et al. have noted group I
fungi related to water damage in homes to be associated
with idiopathic pulmonary hemorrhage.15 By grouping
fungi into these types of environmentally based classifica-
tions, the task of determining potential causation can be
narrowed from a statistical perspective. In this study, 82
molds were screened using QPCR, but only 15 molds were
identified and of these 15 molds, only 13 are part of group
I or group II. Although not statistically proven, a trend
observed in this study was a relation of the presence of
group II molds in patients with sinus disease. It will be
important to consider this type of classification in an at-
tempt to determine the relationship of molds to sinusitis
in a large study with enough statistical power to be con-
fident of the conclusion.
Finally, the descriptive outcomes measures used in this
study show that patients with sinus disease have more
symptoms that are noted in the SNOT-20 survey and de-
creased general health as measured by the SF-36 survey
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with certain domains being more affected than others. In
general, the presence of fungus itself does not seem to cor-
relate with the results of general or specific health outcomes
surveys. In this study, the surveys validated the selection of
patients for the CRS and control group populations.
CONCLUSION
The yield of endoscopically directed middle meatus
brush sampling for QPCR identification of fungi is approx-
imately 45% in patients with CRS and a nondiseased control
population. No statistical difference can be ascribed to the
presence or type of fungi to help differentiate between these
two groups. Consideration of grouping fungi into categories
may help to definitively determine whether or not specific
molds are in fact related to sinus disease.
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